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Abstract: Introduction: Developing imaging agents based on novel porphyrin pharmacophores is of great interest based 
on interesting biological/pharmacological performance when labeled with various radionuclides. 
Method: [
67
Ga] labeled 5,10,15,20-tetrakis (pentafluorophenyl) porphyrin ([
67
Ga]- TFPP) was prepared using [
67
Ga]GaCl3 
and 5,10,15,20-tetrakis (pentafluorophenyl) porphyrin (H2TFPP) for 60 min at reflux condition followed by stability tests, 
partition coefficient determination as well as bio distribution tudies in wild type and tumor bearing animals using 
scarification and SPECT imaging. 
Result: The complex was prepared with acceptable radiochemical purity (>97% ITLC, >98% HPLC, specific activity: 13-
14 GBq/mmol) and stability in final formulation and human serum for 24 h. The partition coefficient was 0.69 (log P). The 
tumor:blood and tumor:muscle uptake ratios were 24.5 and 61.25 respectively after 48 h demonstrating significant 
tumor-imaging property of the tracer. Also confirmed by SPECT imaging. Conclusion: The tracer can be an interesting 
tumor imaging agent due to high specific uptake and rapid excretion through the urinary tract.  
Keywords: Porphyrins, Ga-67, Biodistribution, Imaging agent, SPECT. 
1. INTRODUCTION 
Developing new radiopharmaceuticals based on 
new pharmacophores is still a major area of research in 
the nuclear pharmacy. In this regard, ligands with low 
toxicity, biocompatibility, and significant tumor avidity 
are of great importance in oncological nuclear 
medicine. Porphyrins are good examples of potential 
tumor imaging agents for nuclear, magnetic and optical 
diagnosis when labeled with appropriate metals due to 
the tetrapyrrole moiety. For instance, Motexafin 
gadolinium used in MRI and [1] BOPP used in boron-
neutron capture therapy [2] are main two applications 
of porphyrins in medicine. the development of new 
combined nuclear medicine modalities with higher 
resolution and dual imaging characteristics such as 
SPECT/CT, PET/CT and PET/MRI has attracted great 
efforts in developing diagnostic radiolabeled porphyrins 
in the recent literature including 
99m
Tc-porphyrin 
conjugates [3], 
99m
Tc-porphine[4], 
111
In-m-tetraphenyl 
porphine [5] and
 111
In/
64
Cu-fluoroporphyrins [6, 7]. 
However based on superior imaging qualities of PET 
cameras and the development of efficient PET 
generators including 
68
Ge/
68
Ga
 
with long shelf-life, 
developing radiogallium imaging ligands for ultimate 
PET (Positron emission tomography) imaging is of  
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great interest [8, 9]. In this regard, suitable physical 
properties and availability of gallium-67 [10] suggest a 
robust radiogallium model for feasibility studies in the 
development Ga-68 labeled homologs. 
In continuation of recent efforts in developing 
ultimate radiolabeled porphyrins with desired 
pharmacological properties [11], the idea of developing 
a possible tumor-imaging agent using SPECT by 
incorporating 
67
Ga into a suitable porphyrin ligand, i.e. 
5,10,15,20-tetrakis (pentafluorophenyl) porphyrin 
H2TFPP was investigated (Figure 1). 
In this work we report, synthesis, radiolabeling, 
partition coefficient, quality control and biodistribution 
studies (using SPECT and scarification) of 
67
Ga-TFPP 
in wild-type and tumor-bearing rodents is reported. The 
time/activity diagrams for the labeled compound in vital 
organs have been plotted compared to gallium cation. 
2. MATERIALS AND METHODS 
Enriched zinc-68 chloride with a purity of more than 
95% was obtained from Ion Beam Separation Group at 
Agricultural, Medical and Industrial Research School 
(AMIRS). Production of 
67
Ga was performed at the 
Nuclear Medicine Research Group (AMIRS) 30 MeV 
cyclotron (Cyclone-30, IBA). Other chemicals were 
purchased from the Aldrich Chemical Co. (Gemany); 
and the ion-exchange resins from Bio-Rad Laboratories 
(Canada). NMR spectra were recorded at room 
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temperature on a Bruker AVANCE 300-MHz operating 
at 300.0, 75.0 and 23.3 MHz, respectively, and the 
spectra are referenced to SiMe4. Infrared spectrum was 
measured on a Perkin-Elmer 781 spectrometer using a 
KBr disc. Mass spectrum was recorded by a Finnigan 
Mat TSQ-70 Spectrometer. Thin layer chromatography 
(TLC) for cold compounds was performed on polymer-
backed silica gel (F 1500/LS 254, 20  20 cm, TLC 
Ready Foil, Schleicher & Schuell, Germany). Normal 
saline and sodium acetate used for labeling were of 
high purity and had been filtered through 0.22 μm 
Cativex filters. Instant thin layer chromatography (ITLC) 
was performed by counting Whatman No. 2 papers 
using a thin layer chromatography scanner, Bioscan 
AR2000, Bioscan Europe Ltd. (France). Analytical high 
performance liquid chromatography (HPLC) used to 
determine the specific activity, was performed by a 
Shimadzu LC-10AT, armed with two detector systems, 
flow scintillation analyzer (Packard-150 TR) and UV-
visible (Shimadzu) using Whatman Partisphere C-18 
column 2504.6 mm, Whatman, NJ (USA). Analytical 
HPLC was also used to determine the specific 
radioactivity of the labeled compound. A standard 
curve was generated to calculate the mass of the final 
solution. Biodistribution data were acquired by counting 
normal saline washed tissues after weighting on a 
Canberra high purity germanium (HPGe) detector 
(model GC1020-7500SL). Radionuclidic purity was 
checked with the same detector. For activity 
measurement of the samples a CRC Capintech 
Radiometer (NJ, USA) was used. All calculations and 
tissue countings were based on the 184 keV peak. 
Animal studies were performed in accordance with the 
United Kingdom Biological Council's Guidelines on the 
Use of Living Animals in Scientific Investigations, 2nd 
ed. 
2.1. Production of 
67
Ga 
 
68
Zn(p, 2n)
67
Ga was used as the best nuclear 
reaction for the production of 
67
Ga. Other impurities 
could be removed in the radiochemical separation 
process. After the target bombardment process, 
chemical separation was carried out in no-carrier-
added form. The irradiated target was dissolved in 10 
M HCl (15 ml) and the solution was passed through a 
cation exchange resin (AG 50W, H+ form, mesh 200-
400, h: 10 cm, Ø: 1.3 cm) which had been 
preconditioned by passing 25 ml of 9 M HCl. The 
column was then washed by 25 ml of 9M HCl at a rate 
of 1 ml/min to remove copper and zinc ions. To the 
eluent 30 ml water plus about 100 ml of a 6 M HCl 
solution was added. The latter solution was loaded on 
another exchange resin (AG1X8 Cl
-
 form, 100-200 
mesh, h: 25 cm, Ø: 1.7 cm) pretreated with 6 M HCl 
(100 ml). Finally, the gallium-67 was eluted as 
[
67
Ga]GaCl3 using 2 M HCl (50 ml); the whole process 
took about 60 min. 
2.2. Quality Control of the Product 
2.2.1. Control of Radionuclide Purity 
Gamma spectroscopy of the final sample was 
carried out counting in an HPGe detector coupled to a 
Canberra multi-channel analyzer for 1000 seconds.  
 
Figure 1: A possible molecular formula for 
67
Ga-H2TFPP. 
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2.2.2. Chemical Purity Control  
This step was carried out to ensure that the 
amounts of zinc and copper ions resulting from the 
target material and backing in the final product are 
acceptable regarding internationally accepted limits. 
Chemical purity was checked by differential-pulsed 
anodic stripping polarography. The detection limit of 
our system was 0.1 ppm for both zinc and copper ions.  
2.3. Preparation of Tetraphenyl Porphyrin (H2TFPP)  
This compound was prepared according to the 
reported method using freshly distilled pentafluoro 
benzaldehyde , pyrrole and propionic acid followed by 
oxidation [12]. UV (CH2Cl2) max () = 412,506,584 nm. 
1
HNMR : -2.91 (NH), 9.40 (H) .19FNMR: -136.9 (d), 
151.7(t), -161.8 (m),  
2.4. Preparation of [
67
Ga]-TFPP 
The acidic solution (2 ml) of [
67
Ga]GaCl3 (111 MBq, 
3 mCi) was transferred to a 3 ml-borosilicate vial and 
heated to dryness using a flow of N2 gas at 50-60°C. 
Fifty micreolitres of TFPP in absolute ethanol (5 mg/ml 
409 n moles) was added to the gallium-containing vial 
followed by the addition of acetate buffer pH 5.5 (450 
microliteres). The mixture refluxed at 100°C for 60 min. 
The active solution was checked for radiochemical 
purity by ITLC and HPLC. The final solution was then 
passed through a 0.22 μm filter and pH was adjusted to 
5.5-7.  
2.5. Quality Control of [
67
Ga]-TFPP 
2.5.1. Radio Thin Layer Chromatography 
A 5 μl sample of the final fraction was spotted on a 
chromatography whatman No. 2 paper, and developed 
in mobile phase mixture, 10% NH4OAc and methanol 
1:1.  
2.5.2. High Performance Liquid Chromatography 
HPLC was performed with a flow rate of 1 ml/min, 
pressure: 130 kgF/cm
2
 for 20 min. HPLC was 
performed on the final preparation using a mixture of 
water:acetonitrile 3:2(v/v) as the eluent by means of 
reversed phase column Whatman Partisphere C18 4.6 
 250 mm.  
2.6. Determination of Partition Coefficient 
Partition coefficient (log P) of [
67
Ga]-TFPP was 
calculated followed by the determination of P (P= the 
ratio of specific activities of the organic and aqueous 
phases). A mixture of 1 ml of 1-octanol and 1 ml of 
isotonic acetate-buffered saline (pH=7) containing 
approximately 3.7 MBq of the radiolabeled gallium 
complex at 37°C was vortexed 1 min and left 5 min. 
Following centrifugation at >1200g for 5 min, the 
octanol and aqueous phases were sampled and 
counted in an automatic well-type counter. A 500 μl 
sample of the octanol phase from this experiment was 
shaken again two to three times with fresh buffer 
samples. The reported log P values are the average of 
the second and third extractions from three to four 
independent measurements. 
2.7. Stability Tests 
The stability of the complex was checked according 
to the conventional ITLC method [13]. A sample of 
[
67
Ga]-TFPP (37 MBq) was kept at room temperature 
for 2 days while being checked by ITLC at time 
intervals in order to check stability in final product using 
above chromatography system. For serum stability 
studies, to 36.1 MBq (976 μCi) of [67Ga]-TFPP was 
added 500μl of freshly collected human serum and the 
resulting mixture was incubated at 37°C for 5 h, 
aliquots (5-μl) were analyzed by ITLC.  
2.8. Induction of Fibrosarcoma Tumors in Mice 
Tumor induction performed by the use of poly 
aromatic hydrocarbon injection in rodents as reported 
previously [14]. For tumor model preparation, 10 l of 
3-methyl cholanthrene solution in extra-virgin olive oil 
(4 mg/ml) was injected subcutaneously to the dorsal 
area of the mice. After 14-16 weeks, the tumor weighed 
0.2-0.4 g and was not grossly necrotic. Tumor tissues 
of some random animals were sent for pathological 
tests and were diagnosed as fibrosarcoma.  
2.9. Biodistribution in Wild-type Rats and Swiss 
Mice Bearing Fibro Sarcoma Tumor 
The distribution of the radiolabelled complex among 
tissues was determined for wild-type rats and Swiss 
mice bearing fibro sarcoma tumor immediately after 
imaging. The total amount of radioactivity injected into 
each mouse was measured by counting the 1-ml 
syringe before and after injection in a dose calibrator 
with fixed geometry. The animals were sacrificed using 
animal care protocols at selected times after injection 
(2 to 24h), the tissues as well as the tumor parts were 
weighed and rinsed with normal saline and their 
specific activities were determined with a HPGe 
detector equipped with a sample holder device as 
percent of injected dose per gram of tissues. 
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2.10. Imaging of [
67
Ga]-TFPP in Wild-type Rats and 
Swiss Mice Bearing Fibro Sarcoma Tumor 
Images were taken 2, 4 and 24 hours after 
administration of the radiopharmaceutical by a dual-
head SPECT system. The mouse-to-high energy septa 
distance was 12 cm. Images were taken from both 
normal and tumor bearing mice. The useful field of view 
(UFOV) was 540 mm400 mm.  
3. RESULTS 
3.1. Production 
Gallium-67, in form of GaCl3, was prepared by 24 
MeV proton bombardment of the 
68
Zn target at 
Cyclone-30 on a regular basis. The target was 
bombarded with a current intensity of 170 μA and a 
charge of 1400μAh. The chemical separation process 
was based on a no-carrier-added method.  
Radiochemical separation was performed by a two-
step ion exchange chromatography method with a yield 
of higher than 95%. Quality control of the product was 
performed in two steps. Radionuclidic control showed 
the presence of 93(40%), 184(24%), 296(22%), 
378(7%) keV gamma energies, all originating from 
67
Ga 
and showed a radionuclide purity higher than 99% 
(E.O.S.). The concentrations of zinc (from target 
material) and copper (from target support) were 
determined using polarography and shown to be below 
the internationally accepted levels, i.e. 0.1 ppm for Zn 
and Cu [15, 16]. 
3.2. Radiolabeling 
Chromatographic system was used for the detection 
of the radiolabeled compound from the free gallium 
cation. Using 10% NH4OAc and methanol 1:1 mixture, 
free gallium remains at the origin of the paper as a 
single peak, while the radiolabeled compound migrates 
to higher Rf (0.64) (Figure 2). 
Although the ITLC studies approved the production 
of radiolabeled compound, HPLC studies demonstrated 
the existence of radiolabeled species using both UV 
and scintillation detectors.  
A more fast-eluting compound at 2.2 min 
(scintillation detector) related to 2.4 min peak (UV 
detector) demonstrated a more hydrophilic compound 
while the second peak eluted and 2.8 min (UV 
detector) demonstrated non labeled ligand with a more 
lipophilic property. Free Ga cation eluted at 1.02 
minutes (not shown) (Figure 3.). 
3.3. Partition Coefficient of [
67
Ga]-TFPP 
As expected, the lipophilicity of the [
67
Ga]-TFPP 
compound is rather high. The measured octanol/water 
partition coefficient, P, for the complex was found to 
depend on the pH of the solution. At the pH.7 the logP 
was 0.69. 
3.4. Stability 
The chemical stability of [
67
Ga]-TFPP was high 
enough to perform further studies. Incubation of [
67
Ga]-
TFPP in freshly prepared human serum for 2 days at 
 
Figure 2: Radiochromatograms of the radiolabeled compound (left) and free gallium cation (right) using 10% NH4OAc and 
methanol 1:1 mixture on Whatman paper No.2. 
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37°C showed no loss of 
67
Ga from the complex. The 
radiochemical purity of complex remained at 98% for 2 
days under physiologic conditions.  
3.5. Biodistribution in Normal Rats 
For better comparison biodistribution study was 
performed for free Ga
3+
. The %ID/g data are 
summarized in Figure 4. As reported previously, 
67
Ga is 
excreted majorly from gastrointestinal tract (GIT), thus 
colon and stool activity content are significant while 
blood stream activity is high at 2-4 h followed by 
reduction in 24.  
 
Figure 4: Percentage of injected dose per gram (ID/g %) of 
67
GaCl3 in rat tissues at 0.5, 2, 4 and 24h post injection. 
Bone uptake is also observed after 24 h post 
injection. The radiolabeled compound biodistribution is 
also demonstrated in Figure 5. Due to presence of 
fluorine groups and water solubility of porphyrin 
compounds the major activity in 2 hours post injection 
is present in lung, liver and spleen thus the major route 
of excretion for the labeled compound is urinary tract. 
Thus the excretion of these two organs has a similar 
path. 
On the other hand, due to relative lipophilicity of the 
compound, a major portion of the activity is excreted 
through hepatobiliary tract. 
4. DISCUSSION 
Because of the engagement of NH polar functional 
groups in its structure, labeling of H2TFPP with gallium 
cation affects its chromatographic properties and the 
final complex is more lipophilic. Chromatographic 
systems including HPLC and ITLC were used for the 
detection of the radiolabeled compound from the free 
gallium cation. Although the ITLC studies approved the 
production of radiolabeled compound, HPLC studies 
demonstrated the existence of radiolabeled species 
using both UV and scintillation detectors. Both methods 
demonstrated the formation of a more lipophil complex 
with respect to retention times and retention factors. 
The lipophilicity of complex was also confirmed by 
partition coefficient data.  
Comparison of vital organs uptake for 
67
Ga-TFPP 
and 
67
GaCl3 demonstrates kinetic pattern difference for 
both species. 
67
Ga cation is accumulated in the liver in 
 
Figure 3: HPLC Radiochromatograms of the radiolabeled compound using UV detector (up) and scintillation detector (down) 
using a mixture of water:acetonitrile (40:60) on a reverse phase column. 
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the first 24h post injection slightly, while 
67
Ga-TFPP 
first major excretion route is through the liver (Figure 
6).  
 
Figure 6: Comparative liver activities (%ID/g) for 
67
Ga-TFPP 
and 
67
GaCl3 in wild-type rats from 2-24h post injection. 
 
Figure 7: Comparative bone activities (%ID/g) for 
67
Ga-TFPP 
and 
67
GaCl3 in wild-type rats from 2-24h post injection. 
As shown earlier, 
67
Ga cation is slightly absorbed in 
the skeletal system (2.5-3%) while the labeled 
compound almost shows no uptake in the bone (Figure 
7). 
 
Figure 8: Comparative kidney activities (%ID/g) for 
67
Ga-
TFPP and 
67
GaCl3 in wild-type rats from 2-24h post injection. 
Since the urinary tract is a major route of excretion 
of the porphyrins, and presence of fluorine groups 
increases the solubility of ligand in water, kidney is 
another excretory organ and shows low activity for the 
labeled compound esp after 24h (Figure 8). 
No significant difference in blood activity content is 
observed for free Ga cation and labeled compound. 
(Figure 9.) 
Since the gallium cation can be trapped in blood 
cells due to the high content of thio-proteins, the spleen 
activity content is drastically higher in this organ after 
24h compared to the radiolabeled compound (Figure 
10). 
 
Figure 5: Percentage of injected dose per gram (ID/g %) of [
67
Ga]-TFPP in rat tissues at 0.5, 2, 4 and 24h post injection. 
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Figure 9: Comparative blood activities (%ID/g) for 
67
Ga-
TFPP and 
67
GaCl3 in wild-type rats from 2-24h post injection. 
 
Figure 10: Comparative spleen activities (%ID/g) for 
67
Ga-
TFPP and 
67
GaCl3 in wild-type rats from 2-24h post injection. 
Results of the biodistribution studies revealed good 
tumor uptake (2.005192 %ID/g) within 1h after injection 
and it remained almost better than other organs in 24h 
after injection as expected. The %ID/g data are 
summarized in Figure 11. The ratio of tumor to blood 
2h and 24h post injection are 8.22 and 18.03 
respectively. The ratio of tumor to muscle 2h and 24h 
post injection are 8.22 and 18.03 respectively 15.37 
and 38.15 respectively. 
 
Figure 11: Percentage of injected dose per gram (ID/g %) of 
[
67
Ga]-TFPP in rat tissues at 2, 24 and 48 h post injection. 
The tumor:tissue uptake ratios usually calculated for 
diagnostic agents considering two tissues, i.e. blood 
and muscle responsible for background activity, 
demonstrated the increasing imaging value of the 
tracer by time as shown in Table 1., showing the 
significant tumor imaging property of the tracer.  
Table 1: Tumor:Tissue Uptake Ratios of 
67
Ga-TFPP in 2-
24h p.i 
Ratio/Time 2h 24h 48h 
Tumor: blood 8.22 18.03 24.5 
Tumor: muscle 15.37 38.15 61.25 
 
67
Ga-TFPP imaging in the wild-type rats showed a 
distinct accumulation of the radiotracer in the chest 
region all the time after injection. Most of the activity is 
washed out from the body after 24h and the picture 
 
Figure 12: SPECT images of 
67
Ga-TFPP in wild type rats 2, 4 and 24 h (a-c resp.) post injection compared to the 
67
Ga cation 
image (d). 
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contrast weakened. While a typical Ga-67 scan is 
usually high chest and abdomen activity accumulation 
remaining at least 48 hours in the rat body. 
As shown in Figure 13, in a good accordance with 
67
Ga-TFPP imaging in normal rats the swiss mice 
bearing fibro sarcoma tumor showed accumulation of 
the radiotracer in the chest region and tumor after 
injection. Most of the activity is washed out from the 
body after 24h and the rest remains in tumor.  
 
Figure 13: SPECT images of 
67
Ga-TFPP in mice bearing 
fibro sarcoma tumor 24 h post injection compared to the 
anatomical site. 
5. CONCLUSIONS 
Total labeling and formulation of [
67
Ga]-TFPP took 
about 30-60 min (RCP >97% ITLC, >98% HPLC, 
specific activity: 13-14 GBq/mmol). The complex was 
stable in final formulation and human serum at least for 
24 h. At the pH.7, the logP was 0.69. The 
biodistribution of the labeled compound in vital organs 
of wild-type rats was studied using scarification studies 
and SPECT imaging up to 24 h.  
A detailed comparative pharmacokinetic study 
performed for 
67
Ga cation and [
67
Ga]-TFPP. The 
tumor:blood and tumor:muscle uptake ratios were 24.5 
and 61.25 respectively after 48 h demonstrating 
significant tumor-imaging property of the tracer value of 
the tracer. SPECT imaging also confirmed the results 
in 24h. The tracer can be an interesting tumor imaging 
agent due to high specific uptake and rapid excretion 
through the urinary tract. It is suggested that 
67
Ga-
TFPP could be a possible SPECT tracer, however 
considering the well targeted treatment of this 
compound in chest region, fast wash-out and the short 
half life gallium-68,
67
Ga TFPP can be a suitable 
candidate for tumor imaging applications and future 
68
Ga-PET studies and less use and therefore less 
imposed radiation doses to patients. 
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